R-GOLIX 120MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: IPCA LABORATORIES LTD (ONCOLOGY DIV)

MRP: ₹5142.85

IPCA LABORATORIES LTD (ONCOLOGY DIV): R-golix 120MG Tablet, 30 tablets, salt relugolix 120mg. NPPA has revised its MRP from Rs 6,562.50 to Rs 5,142.85 (22% lower) with effect from 09-11-2026; trade rate Rs 3,918.36. Group: oral GnRH antagonist (hormone therapy). Same salt is also supplied by Abbott, Cipla, Glenmark, Natco, Samarth and others. Handling/counselling: check the strength: 120 mg is the prostate-cancer product. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.